Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.040
-0.030 (-2.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $33.21 million as of November 21, 2024. Its market cap has decreased by -11.60% in one year.
Market Cap
33.21M
Enterprise Value
-2.09M
1-Year Change
-11.60%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $69.28M to $33.21M, a decrease of -52.07%. That is a compound annual growth rate of -9.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroGen | 35.27M |
| OKYO Pharma | 34.85M |
| Citius Pharmaceuticals | 34.66M |
| Iterum Therapeutics | 34.51M |
| Elevation Oncology | 34.29M |
| Precision Optics Corporation | 33.78M |
| HOOKIPA Pharma | 33.63M |
| Moolec Science | 33.44M |